XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Interim Consolidated Statements of Stockholders’ Equity (Deficiency) (Unaudited) - USD ($)
Common Shares
Preferred Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 39,760,287 $ 62 $ 17,288,430 $ (104,301) $ (61,648,173) $ (4,703,695)
Balance (in Shares) at Dec. 31, 2023 4,728,355 316,655        
Units issued for cash $ 3,732,469 3,732,469
Units issued for cash (in Shares) 678,630          
Shares issued for services $ 2,273,949         2,273,949
Shares issued for services (in Shares) 413,445          
Share issuance costs $ (987,988) 582,245 (405,743)
Share issuance costs (in Shares) 168,886          
Options exercised $ 36,751 (36,751)
Options exercised (in Shares) 7,700          
Share-based compensation 348,085 348,085
Reallocation of derivative liability on re-pricing of warrants from CAD to USD exercise price 4,292,797 4,292,797
Net loss (5,002,711) (5,002,711)
Balance at Mar. 31, 2024 $ 49,108,265 $ 62 18,182,009 (104,301) (66,650,884) 535,151
Balance (in Shares) at Mar. 31, 2024 5,997,016 316,655        
Balance at Dec. 31, 2024 $ 99,128,230 $ 62 18,724,092 (104,301) (76,285,038) 41,463,045
Balance (in Shares) at Dec. 31, 2024 16,019,787 316,655        
Share-based compensation 1,355,373 1,355,373
Net loss (2,006,543) (2,006,543)
Balance at Mar. 31, 2025 $ 99,128,230 $ 62 $ 20,079,465 $ (104,301) $ (78,291,581) $ 40,811,875
Balance (in Shares) at Mar. 31, 2025 16,019,787 316,655